Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 1
1979 2
1980 4
1981 9
1982 5
1983 7
1984 10
1985 10
1986 10
1987 19
1988 19
1989 29
1990 15
1991 43
1992 34
1993 39
1994 44
1995 60
1996 63
1997 67
1998 76
1999 94
2000 73
2001 91
2002 103
2003 150
2004 219
2005 221
2006 278
2007 284
2008 349
2009 403
2010 521
2011 602
2012 690
2013 851
2014 922
2015 982
2016 1073
2017 1222
2018 1423
2019 1715
2020 2052
2021 2238
2022 2534
2023 2431
2024 2724
2025 3297
2026 1049

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,759 results

Results by year

Filters applied: . Clear all
Page 1
Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis.
Hu Y, Yang B, Xiao C, Yang X, Zhang H, Yang P, Du X, Zhang G, Liang B, Bai N, Zhang D, Wu D, Luo Q, Teng Y, Chen Y, Guo Z, Zhao C, Ye T, Chai D, Qi X, Zhong W, Chen J, Dong H, Gao J, He H, Chang J, Li X, Peng L, Rafii S, Friedman SL, Yi C, Cai Y, Zhao Y, Wang H, Wang C, Cao Z, Ding BS. Hu Y, et al. Among authors: yang b. Cell. 2026 Mar 6:S0092-8674(26)00166-2. doi: 10.1016/j.cell.2026.02.001. Online ahead of print. Cell. 2026. PMID: 41794026
Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial.
Shen Y, Zeng C, Sun Y, Wang J, Yu B, Cheng X, Guo X, Wang DW, Li Y, Han W, Zhou B, Sheng H, Huang Z, Li Y, Fu G, Zhang J, Xie D, Liang D, Liu Y, Yang B, Zhang Q, Duan R, Li H, Zhang B, Wu Y, Zheng L, He J, Liu S, Yin D, Sun G, Zhang S, Guo X, Zhang M, Wang Y, Hu X, Zeng J, Yang X, Li S, Li N, Hu F, Wang H, Hu X, Wang Y, Zeng C, Wang K, Yang J, Wang Y, Lai J, Wang L, Xiong K, Wang G, Zou Q, Shao B, Chen Z, Wu Y, Leng J, Pu J, Ma C, Chen YH. Shen Y, et al. Among authors: yang b. Circulation. 2026 Mar 19. doi: 10.1161/CIRCULATIONAHA.125.079023. Online ahead of print. Circulation. 2026. PMID: 41853846 Free article.
ChatGPT in precision medicine.
Yin C, Sun X, Dai A, Ye XY, Lu Y, Wang W, Chen Y, Jiang H, Yu J, Chong S, Jiang M, Xu J, Yang B, Chappa R, Chokkakula S, He K. Yin C, et al. Among authors: yang b. APL Bioeng. 2026 Mar 17;10(1):011502. doi: 10.1063/5.0299327. eCollection 2026 Mar. APL Bioeng. 2026. PMID: 41859300 Free PMC article. Review.
Spatial tumor evolution panorama of ovarian cancer.
Feng C, Yang Y, Li G, Fang Z, Yang B, Zhao F, Chen X, Liu S, Wu D, Hu X, Yin J, Zhang S, Fan J, Peng W, Hu Z, Wu Z, Fu Y, Lu F, Qin T, Wang B, Mills GB, Zhou X, Li J, Zhu T, Fei P, Wang P, Ma D, Li F, Chen G, Sun C. Feng C, et al. Among authors: yang b. Cell Rep Med. 2026 Mar 17;7(3):102666. doi: 10.1016/j.xcrm.2026.102666. Cell Rep Med. 2026. PMID: 41850247 Free PMC article.
Deucravacitinib-induced cutaneous hypersensitivity reactions.
Wang Q, Qu P, Zhao X, Yang X, Ao S, Song P, Shan X, Yang B. Wang Q, et al. Among authors: yang b. Postgrad Med J. 2026 Mar 13:qgag028. doi: 10.1093/postmj/qgag028. Online ahead of print. Postgrad Med J. 2026. PMID: 41824396 No abstract available.
DGAT1 mediates sex-specific CD8+ T cell antitumour responses.
Madi A, Shi H, Su M, Mady A, Lv B, Wang H, Yang B, Yan Z, Jin X, Wu L, Lv M, Hering M, Ma S, Mieg A, Zettl F, Yan X, Mohr K, Knabe N, Poschet G, Richter K, Schleußner N, Jackstadt RF, Loges S, Papavasiliou FN, Wang X, Wu J, Cui G. Madi A, et al. Among authors: yang b. Nat Metab. 2026 Mar;8(3):685-703. doi: 10.1038/s42255-026-01462-7. Epub 2026 Mar 20. Nat Metab. 2026. PMID: 41862754
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.
Sun Y, Yang H, Wang J, Lou H, Li D, Wang K, Zhang H, Wu T, Li Y, Wang C, Li G, Wang Y, Li D, Tang Y, Pan M, Cai H, Wang W, Yang B, Qian H, Tian Q, Yao D, Cheng Y, Wei B, Li X, Wang T, Hao M, Wang X, Wang T, Liu C, Zhu H, Zhu L, Liu X, Li Y, Chen L, Li Q, Yan X, Wang F, Cai H, Zhang Y, Liang Z, Liu F, Huang Y, Xia B, Qu P, Zhu G, Chen Y, Song K, Sun M, Chen Z, Zhou Q, Hu L, Abulizi G, Guo H, Liao S, Ye Y, Yan P, Tang Q, Sun G, Liu T, Lu D, Hu M, Wang ZM, Li B, Xia M, Wu X. Sun Y, et al. Among authors: yang b. Nat Commun. 2026 Mar 14. doi: 10.1038/s41467-026-69965-1. Online ahead of print. Nat Commun. 2026. PMID: 41826281 Free article.
25,759 results
You have reached the last available page of results. Please see the User Guide for more information.